CD274 and glioblastoma: These findings indicate that [18F]AlF-NOTA-PCP2 offers a sensitive, specific, and safe method for noninvasive, real-time visualization of PD-L1-driven radioresistance in glioblastoma, supporting its potential role in guiding personalized radiotherapy and immunotherapy strategies.